Pure Appl. Chem., 2007, Vol. 79, No. 4, pp. 469-479
http://dx.doi.org/10.1351/pac200779040469
Development of huperzine A and B for treatment of Alzheimer's disease
CrossRef Cited-by Linking
- Drtinova Lucie, Dobes Petr, Pohanka Miroslav: Low molecular weight precursor applicable for Alzheimer disease drugs synthesis (AChE and BChE inhibition, BACE inhibition, antioxidant properties and in silico modulation). Journal of Applied Biomedicine 2014. <http://dx.doi.org/10.1016/j.jab.2014.01.010>
- Ishiuchi Kan’ichiro, Park Jeong-Jin, Long Robert M., Gang David R.: Production of huperzine A and other Lycopodium alkaloids in Huperzia species grown under controlled conditions and in vitro. Phytochemistry 2013, 91, 208. <http://dx.doi.org/10.1016/j.phytochem.2012.11.012>
- Ding Rui, Lu YunYu, Yao HeQuan, Sun BingFeng, Lin GuoQiang: A new approach to the bicyclo[3.3.1]nonane framework of huperzine A-like molecules via palladium-catalyzed intramolecular γ-arylation. Sci. China Chem. 2012, 55, 1097. <http://dx.doi.org/10.1007/s11426-011-4480-y>
- Ding Xiao-Hua, Li Xiang, Liu Dan, Cui Wei-Chen, Ju Xuan, Wang Shaozhong, Yao Zhu-Jun: Target-oriented multifunctional organocatalysis for enantioselective synthesis of bicyclo[3.3.1]nona-2,6-dien-9-ones. A formal asymmetric synthesis of huperzine A. Tetrahedron 2012, 68, 6240. <http://dx.doi.org/10.1016/j.tet.2012.05.061>
- Lin Hong-Yu, Causey Robert, Garcia Gregory E., Snider Barry B.: Synthesis of (±)-7-Hydroxylycopodine. J. Org. Chem. 2012, 77, 7143. <http://dx.doi.org/10.1021/jo300353t>
- Ding Rui, Sun Bing-Feng, Lin Guo-Qiang: An Efficient Total Synthesis of (−)-Huperzine A‡. Org. Lett. 2012, 14, 4446. <http://dx.doi.org/10.1021/ol301951r>
- Mehta Mona, Adem Abdu, Sabbagh Marwan: New Acetylcholinesterase Inhibitors for Alzheimer's Disease. International Journal of Alzheimer's Disease 2012, 2012, 1. <http://dx.doi.org/10.1155/2012/728983>
- Ha Giang T., Wong Ryan K., Zhang Yan: Huperzine A as Potential Treatment of Alzheimer's Disease: An Assessment on Chemistry, Pharmacology, and Clinical Studies. C&B 2011, 8, 1189. <http://dx.doi.org/10.1002/cbdv.201000269>
- Pohanka Miroslav: Cholinesterases, a target of pharmacology and toxicology. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2011, 155, 219. <http://dx.doi.org/10.5507/bp.2011.036>
- Grondal Christoph, Jeanty Matthieu, Enders Dieter: Organocatalytic cascade reactions as a new tool in total synthesis. Nature Chem 2010, 2, 167. <http://dx.doi.org/10.1038/nchem.539>
- Silvestri Romano: Boom in the development of non-peptidic β-secretase (BACE1) inhibitors for the treatment of Alzheimer's disease. Med Res Rev 2009, 29, 295. <http://dx.doi.org/10.1002/med.20132>
- Haigh Julian R., Johnston Scott R., Peppernay Adam, Mattern Patrick J., Garcia Gregory E., Doctor Bhupendra P., Gordon Richard K., Aisen Paul S.: Protection of red blood cell acetylcholinesterase by oral huperzine A against ex vivo soman exposure: Next generation prophylaxis and sequestering of acetylcholinesterase over butyrylcholinesterase. Chemico Biological Interactions 2008, 175, 380. <http://dx.doi.org/10.1016/j.cbi.2008.04.033>